ThomasNet News Logo
Sign Up | Log In | ThomasNet Home | Promote Your Business

IOMED Schedules Special Shareholders' Meeting for August 8 to Vote on Proposed Merger with ReAble Therapeutics

Print | 
Email |  Comment   Share  

(Archive News Story - Products mentioned in this Archive News Story may or may not be available from the manufacturer.)

IOMED®, Inc.
2441 So. 3850 West
Salt Lake City, UT, 84120
USA



Press release date: July 10, 2007

Sets Record Date and Announces Amendment to Merger Agreement

SALT LAKE CITY, July 10 -- IOMED, Inc. (AMEX:IOX) today announced that it has called a special meeting of shareholders for August 8, 2007 at 10:00 a.m. local time to be held at IOMED headquarters located at 2441 South 3850 West, Salt Lake City, Utah. The record date for the special meeting to vote on the proposed acquisition of IOMED by ReAble Therapeutics, Inc. is July 6, 2007.

IOMED filed definitive proxy materials relating to the special meeting, recommending shareholders vote for the previously announced transaction, with the Securities and Exchange Commission on July 9, 2007. Those materials will soon be mailed to shareholders. IOMED's Board of Directors has approved the merger agreement and recommends that its shareholders vote "for" the approval and adoption of the merger agreement.

Shareholders entitled to vote at the special meeting may vote by following the instructions included in the proxy statement and printed on the proxy card or by following the directions provided by their individual broker dealer firm. Failure to vote or abstaining from voting will have the same effect as a vote against the proposed transaction.

In addition, IOMED announced the signing of an amendment, dated July 6, 2007, to the merger agreement. The amendment extends the termination date from July 31, 2007 to August 31, 2007.

IOMED is a leader in developing, manufacturing and marketing active drug delivery systems used primarily to treat acute local inflammation in the physical and occupational therapy and sports medicine markets. The Company is pursuing opportunities to advance its position as a provider of quality, innovative non-invasive medical products that improve patient healthcare. To find out more about IOMED, Inc. (AMEX:IOX), visit our website at http://www.iomed.com

Source: IOMED, Inc.

Web site: http://www.iomed.com/
Print | 
Email |  Comment   Share  
Contacts: View detailed contact information.


 

Post a comment about this story

Name:
E-mail:
(your e-mail address will not be posted)
Comment title:
Comment:
To submit comment, enter the security code shown below and press 'Post Comment'.
 



-- IMT - News | IMTREG2 |  18716 --
Start Your Free
Subscription to
Industry Market Trends.
 More New Product News from this company:
Active Drug Delivery System utilizes iontophoresis.
More ....
 Other News from this company:
IOMED Receives Shareholder Approval of Merger Agreement with ReAble Therapeutics
IOMED & ReAble Therapeutics Merger Consideration Established at $2.75 Per Share
IOMED, Inc. to Be Acquired by ReAble Therapeutics
More ....
 Tools for you
Watch Company 
View Company Profile
Company web site
More news from this company
E-Mail Story
Save Story


Home  |  My ThomasNet News®  |  Industry Market Trends®  |  Submit Release  |  Advertise  |  Contact News  |  About Us
Brought to you by Thomasnet.com        Browse ThomasNet Directory

Copyright © 2013 Thomas Publishing Company. All Rights Reserved.
Terms of Use - Privacy Policy



Error close

Please enter a valid email address